Literature DB >> 2440462

Effects of irradiation with conventional and multiple daily fractionation on serum amylase activity.

A Becciolini, S Porciani, A Lanini, A Chiavacci, E Cellai.   

Abstract

The behaviour of serum alpha-amylase activity was determined in patients with head and neck cancer treated by radiation therapy. The levels of serum alpha-amylase activity during conventional and multiple daily fractionation were compared. Starting from the second day of treatment an increase of serum alpha-amylase activity was observed. The increase and its duration depended on the total daily dose: after the first day of treatment a linear correlation between serum levels and total daily dose could be observed. The size of the amylase increase correlated to the proportion of salivary gland tissue included in the irradiated volume.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2440462     DOI： 10.3109/02841868709091753

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


  3 in total

1.  Serum amylase and tissue polypeptide antigen as biochemical indicators of salivary gland injury during iodine-131 therapy.

Authors:  A Becciolini; S Porciani; A Lanini; A Benucci; A Castagnoli; A Pupi
Journal:  Eur J Nucl Med       Date:  1994-10

Review 2.  Radiation therapy and serum salivary amylase in head and neck cancer.

Authors:  Francesca De Felice; Mario Tombolini; Angela Musella; Francesco Marampon; Vincenzo Tombolini; Daniela Musio
Journal:  Oncotarget       Date:  2017-06-28

3.  Relationship between Salivary Amylase and Xerostomia in Intensity-Modulated Radiation Therapy for Head and Neck Cancer: A Prospective Pilot Study.

Authors:  Francesca De Felice; Maria Giulia Scarabelli; Raffaella De Pietro; Giuseppina Chiarello; Federico Di Giammarco; Carlo Guglielmo Cattaneo; Giuliana Lombardo; Francesca Romana Montinaro; Miriam Tomaciello; Mario Tombolini; Daniela Messineo; Pier Luigi Di Paolo; Claudia Marchetti; Daniela Musio; Vincenzo Tombolini
Journal:  Curr Oncol       Date:  2022-09-15       Impact factor: 3.109
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.